Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00746746
Brief Title: A Phase II Study of an Anti-Tumor Immunotherapy Regimen Comprised of Pegylated Interferon-Alpha 2b and HyperAcute Melanoma Vaccine for Subjects With Advanced Melanoma

First Submitted : September 3, 2008
First Submitted that Met QC Criteria : September 3, 2008
First Posted : September 4, 2008 (Estimate)

Last Update Submitted that Met QC Criteria : January 12, 2011
Last Update Posted : January 13, 2011 (Estimate)